The new and exciting about Acomplia is that it functions very differently to the other medication in the same field such as  Reductil and Xenical.  Reductil is also an appetite srepressant but it does not work in the same way as Acomplia does. Acomplia it really works on  the  receptors that are located in the brain and which control the appetite. Acomplia it is produced by the firm Sanofi-Aventis,which is located in France.

A few years back another very big drug company named Merck decided to produs a drug similar that would stimulate the brain receptors and in this way to control the desire to eat in the same way as acomplia and have been extreamly busy with a phase 3 clinical trial. This new diet medication is named taranabant and the wisspers that we have heard from Ukmedix News sais that the results have been very good.

Almost two and a half thousand men and women have been testing the medication in the last 2 years and based on the power of the clinical results all the world  expectes that Merck will file a good application in order to be  approved the new drug(rival of acomplia) to the Food & Drug Administration next year, possible in the second quarter of 2008. As is being practiced for everyone very little informations have been given to the media by the drug company Merck that refers to the results of the trials.However from this  little information coming from the people that participated in the clinical trials it seems that things are doing very well.

Drugs,like acomplia, that help you to loss weight are in great demand all over the globe as so many developed states are dealling with a great  number of obese people. Obesity generates costs in the whole world at the level of billions of pounds each year in medical bills and the financial returns on weight loss medication have great potential.

Importantt scientific advances have been done in drugs(such as acomplia) over the last few years that specifically work on the receptors located in the brain and  companies that produce drugs are  investing very much in such a type of research. It is expected that over the next few decades the world will see lots of drugs on the market to cure a whole list of ailments from a neurological angle as opposed to a physical point of view.